Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia

Abstract Background Acute promyelocytic leukaemia (APL) is a unique subtype of acute myeloid leukaemia (AML) characterized by haematopoietic failure caused by the accumulation of abnormal promyelocytic cells in bone marrow (BM). However, indispensable BM biopsy frequently afflicts patients in leukae...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Guiran Wang, Guiling Yan, Kanru Sang, Huijie Yang, Ni Sun, Yuanyuan Bai, Feng Xu, Xiaoqun Zheng, Zhanguo Chen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMC 2022-05-01
Cyfres:BMC Cancer
Pynciau:
Lnc-LOC
Acute promyelocytic leukaemia
Minimal residual disease
Noninvasive biomarker
Surveillance
Mynediad Ar-lein:https://doi.org/10.1186/s12885-022-09621-1
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg